How many chronic myeloid leukemia patients who started a...

  • Main
  • 2020 / 04
  • How many chronic myeloid leukemia patients who started a...
Cancer Medicine 2020 / 04

How many chronic myeloid leukemia patients who started a frontline second‐generation tyrosine kinase inhibitor have to switch to a second‐line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)

Breccia, Massimo, Olimpieri, Pier Paolo, Olimpieri, Odoardo, Pane, Fabrizio, Iurlo, Alessandra, Foggi, Paolo, Cirilli, Alessia, Colatrella, Antonietta, Cuomo, Marcello, Gozzo, Lucia, Summa, Valentina,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Cancer Medicine
DOI:
10.1002/cam4.3071
Date:
April, 2020
File:
PDF, 349 KB
2020
Conversion to is in progress
Conversion to is failed